About the Company
We do not have any company description for Profound Medical Corp. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Profound Medical Corp.
Profound Medical Corp. (NASDAQ:PROF) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript August 14, 2025 Profound Medical Corp. misses on earnings expectations. Reported EPS is ...
Profound Medical Corp (PROF) Q2 2025 Earnings Call Highlights: Navigating Challenges with ...
Despite revenue setbacks, Profound Medical Corp (PROF) showcases strong margins, a robust pipeline, and innovative ...
Profound Medical Announces Second Quarter 2025 Financial Results
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapies for ...
Profound Medical Reports Q2 2025 Growth and New Innovations in Prostate Treatment
Profound Medical ( ($TSE:PRN) ) just unveiled an update. Profound Medical reported its second quarter 2025 financial results, highlighting a 10% ...
Profound Medical Corp. (PROF) Q3 2023 Earnings Call Transcript
Profound Medical Corp. (NASDAQ: PROF) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Stephen Kilmer - IR Arun Menawat - Chairman and CEO Rashed Dewan - CFO ...
Save the Date: Profound Medical to Host Investor Event at AUA 2025
--Profound Medical Corp., a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will host a hybrid investor ...
Profound Medical Announces Fourth Quarter and Full Year 2023 Financial ...
TORONTO, March 07, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets ...
Profound Medical Corp. Completes Acquisition of Royal Philips ...
TORONTO, July 31, 2017 (GLOBE NEWSWIRE) -- With reference to its press release dated June 30, 2017, Profound Medical Corp. (TSXV:PRN) (OTCQX:PRFMF) (“Profound”) announced today that all ...
Profound Medical Corp.: Profound Medical Announces Second Quarter 2025 Financial Results
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets customizable ...
Profound Medical Corp. (PROF) Q2 2025 Earnings Call Transcript
Profound Medical (PROF) reviews Q2 2025 results, focusing on TULSA-PRO pipeline growth, AI-powered BPH solutions & trials driving adoption.
Similar Companies
Loading the latest forecasts...